Compare NIO Inc. (NIO) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NIO Inc. vs Tempus AI — how do they compare? NIO Inc. trades at $3.46 (market cap $8.67B), while Tempus AI trades at $70.55 (market cap $12.77B). The key difference: Tempus AI is the larger of the two by market cap, and Tempus AI is trading nearer its 52-week high, NIO Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold NIO Inc. for 81 Days and Tempus AI for 22 Days on average.
| NIO | TEM | |
|---|---|---|
Market Cap | $8.67B | $12.77B |
Volume | 25,622,800 | 8,980,490 |
Sector | Consumer Cyclical | Broad Market / Factor |
52-Week High | $7.46 | $99.28 |
52-Week Low | $3.37 | $41.55 |
Typical Hold Time | 81 Days | 22 Days |
Enterprise Value | $6.57B | $13.40B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NIO trades at $3.54, down 55% from its 52-week high, with a bearish technical signal despite recent earnings beats. The company shows improving revenue growth (2025: $87.5B) and narrowing losses (net margin: -17.8% in 2025 vs -34.5% in 2024), supported by a strategic battery-swap partnership with Geely. However, negative cash flow (-$10.9B in 2024) and high debt ($20.6B total debt) remain concerns.
The stock offers speculative upside to the $6.23 analyst target (76% potential) but faces significant execution risks in China's competitive EV market. Investors must weigh improving fundamentals against persistent profitability challenges and macroeconomic headwinds.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite negative profitability. Recent FDA clearance for its ECG-MR AI product and 13 abstracts accepted for ESMO Congress 2026 highlight ongoing innovation. Revenue grew to $1.4B in 2026, though net losses persist. The stock shows strong analyst support with a $72.60 consensus target and 64% buy ratings.
Outlook remains cautiously optimistic driven by AI healthcare adoption and data licensing growth, but high valuation multiples and sustained losses pose risks. Investor sentiment is positive amid recent insider selling and institutional interest, yet profitability challenges and competitive pressures require monitoring for long-term value creation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About NIO Inc.
NIO Inc. manufactures and sells automobiles. The Company offers electric vehicles and parts, as well as provides battery charging services. NIO serves customers worldwide.
Read more on NIO →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
